CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance

Go back to CareMax (CMAX) Misses Q2 EPS by 21c; Offers FY23 Revenue Guidance

CareMax Reports Second Quarter 2023 Results

August 9, 2023 6:55 AM EDT

Second Quarter Medicare Advantage Membership of 102,500, up 177% year-over-year Second Quarter Total Revenue of $224.4 million, up 30% year-over-year Raising Full Year 2023 Revenue Guidance; Reaffirming Full Year 2023 Adjusted EBITDA Guidance

MIAMI--(BUSINESS WIRE)-- CareMax, Inc. (NASDAQ: CMAX; CMAXW) (CareMax or the Company), a leading technology-enabled value-based care delivery system, today announced financial results for the second quarter ended June 30, 2023.

We continued to deliver on our growth strategy, ending the quarter with 102,500 Medicare Advantage members, up 177% year-over-year, and have confidence in achieving both our near and long-term membership targets that we... More